Unlock stock picks and a broker-level newsfeed that powers Wall Street.
76,600.00
+600.00
+(0.79%)
At close: April 4 at 3:30:15 PM GMT+9
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
407,807,117.93
407,807,117.93
393,188,581.13
355,865,975.04
291,529,687.47
Cost of Revenue
147,555,911.29
147,555,911.29
114,349,186.90
95,189,764.79
98,375,867.02
Gross Profit
260,251,206.64
260,251,206.64
278,839,394.23
260,676,210.25
193,153,820.45
Operating Expense
161,750,727
161,750,727
140,560,137
134,951,237
122,980,947
Operating Income
98,500,479.64
98,500,479.64
138,279,257.23
125,724,973.25
70,172,873.45
Net Non Operating Interest Income Expense
-8,504,097.74
-8,504,097.74
-6,131,176.55
-6,109,534.68
-5,744,097.36
Pretax Income
93,932,532.97
93,932,532.97
134,480,213.25
118,394,778.99
74,717,705.31
Tax Provision
21,522,379.05
21,522,379.05
37,954,241.14
32,250,961.28
19,218,302.50
Net Income Common Stockholders
72,710,126.07
72,710,126.07
96,524,197.06
86,066,136.12
55,484,056.50
Basic EPS
8.43k
--
11.19k
9.98k
6.43k
Diluted EPS
8.43k
--
11.19k
9.98k
6.43k
Basic Average Shares
8,624.14
--
8,623.62
8,623.86
8,623.57
Diluted Average Shares
8,624.14
--
8,623.62
8,623.86
8,623.57
Total Operating Income as Reported
98,497,363.46
98,497,363.46
138,279,256.79
125,702,600.21
69,882,395.49
Rent Expense Supplemental
1,115,743
1,115,743
1,430,205
282,224
542,773
Total Expenses
309,306,638.29
309,306,638.29
254,909,323.90
230,141,001.79
221,356,814.02
Net Income from Continuing & Discontinued Operation
72,710,126.07
72,710,126.07
96,524,197.06
86,066,136.12
55,484,056.50
Normalized Income
85,655,042.75
85,655,042.75
96,863,493.78
86,073,996.36
55,040,431.66
Interest Income
1,080,676
1,080,676
1,302,206
683,379
333,056
Interest Expense
9,584,774
9,584,774
7,433,383
6,792,914
6,077,153
Net Interest Income
-8,504,097.74
-8,504,097.74
-6,131,176.55
-6,109,534.68
-5,744,097.36
EBIT
103,517,306.97
103,517,306.97
141,913,596.25
125,187,692.99
80,794,858.31
EBITDA
126,723,514.97
126,723,514.97
162,797,760.25
144,136,237.99
94,000,501.31
Reconciled Cost of Revenue
147,555,911.29
147,555,911.29
114,349,186.90
95,189,764.79
98,375,867.02
Reconciled Depreciation
23,206,208
23,206,208
20,884,164
18,948,545
13,205,643
Net Income from Continuing Operation Net Minority Interest
72,710,126.07
72,710,126.07
96,524,197.06
86,066,136.12
55,484,056.50
Total Unusual Items Excluding Goodwill
-16,792,518
-16,792,518
-472,709
-10,803
597,243
Total Unusual Items
-16,792,518
-16,792,518
-472,709
-10,803
597,243
Normalized EBITDA
143,516,032.97
143,516,032.97
163,270,469.25
144,147,040.99
93,403,258.31
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-3,847,601.32
-3,847,601.32
-133,412.28
-2,942.76
153,618.16
12/31/2021 - 3/16/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1ISRG.MI Intuitive Surgical, Inc.
423.90
-6.09%
ALCz.XC
AFX.BE Carl Zeiss Meditec AG
48.40
-6.47%
FIE.DE Fielmann Group AG
40.45
-3.35%
CEOS Psykey, Inc.
0.0055
-31.25%
ALSPW.PA Spineway SA
0.1140
-5.79%
CZMWY Carl Zeiss Meditec AG
53.40
-6.15%
TGLVY Top Glove Corporation Bhd.
0.8052
0.00%
6699.HK Angelalign Technology Inc.
55.550
-1.07%
AMS.L Advanced Medical Solutions Group plc
208.00
-4.81%